Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen, which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. The company also develops and invests in stem cell and medical technology. Diamyd Medical was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28
Frequently Asked Questions
What is Market Cap of Diamyd Medical AB - Ordinary Shares - Class B?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Diamyd Medical AB - Ordinary Shares - Class B market cap is $100.38M.
What is the 52-week high for Diamyd Medical AB - Ordinary Shares - Class B?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Diamyd Medical AB - Ordinary Shares - Class B 52 week high is $0.73 as of September 06, 2025.
What is the 52-week low for Diamyd Medical AB - Ordinary Shares - Class B?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Diamyd Medical AB - Ordinary Shares - Class B 52 week low is $0.73 as of September 06, 2025.
What is Diamyd Medical AB - Ordinary Shares - Class B stock price today?
Diamyd Medical AB - Ordinary Shares - Class B stock price today is $0.73.
What is the PE ratio of Diamyd Medical AB - Ordinary Shares - Class B?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Diamyd Medical AB - Ordinary Shares - Class B’s P/E ratio is -4.51.
What is the Price-to-Book ratio of Diamyd Medical AB - Ordinary Shares - Class B?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Diamyd Medical AB - Ordinary Shares - Class B P/B ratio is 2.9694.
What is the 50-day moving average of Diamyd Medical AB - Ordinary Shares - Class B?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Diamyd Medical AB - Ordinary Shares - Class B 50-day moving average is $0.73.
How many employess does Diamyd Medical AB - Ordinary Shares - Class B has?
Diamyd Medical AB - Ordinary Shares - Class B has 28 employees.
